Document Detail


Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles.
MedLine Citation:
PMID:  20668118     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To investigate the potential of spectral computed tomography (CT) (popularly referred to as multicolor CT), used in combination with a gold high-density lipoprotein nanoparticle contrast agent (Au-HDL), for characterization of macrophage burden, calcification, and stenosis of atherosclerotic plaques.
MATERIALS AND METHODS: The local animal care committee approved all animal experiments. A preclinical spectral CT system in which incident x-rays are divided into six different energy bins was used for multicolor imaging. Au-HDL, an iodine-based contrast agent, and calcium phosphate were imaged in a variety of phantoms. Apolipoprotein E knockout (apo E-KO) mice were used as the model for atherosclerosis. Gold nanoparticles targeted to atherosclerosis (Au-HDL) were intravenously injected at a dose of 500 mg per kilogram of body weight. Iodine-based contrast material was injected 24 hours later, after which the mice were imaged. Wild-type mice were used as controls. Macrophage targeting by Au-HDL was further evaluated by using transmission electron microscopy and confocal microscopy of aorta sections.
RESULTS: Multicolor CT enabled differentiation of Au-HDL, iodine-based contrast material, and calcium phosphate in the phantoms. Accumulations of Au-HDL were detected in the aortas of the apo E-KO mice, while the iodine-based contrast agent and the calcium-rich tissue could also be detected and thus facilitated visualization of the vasculature and bones (skeleton), respectively, during a single scanning examination. Microscopy revealed Au-HDL to be primarily localized in the macrophages on the aorta sections; hence, the multicolor CT images provided information about the macrophage burden.
CONCLUSION: Spectral CT used with carefully chosen contrast agents may yield valuable information about atherosclerotic plaque composition.
Authors:
David P Cormode; Ewald Roessl; Axel Thran; Torjus Skajaa; Ronald E Gordon; Jens-Peter Schlomka; Valentin Fuster; Edward A Fisher; Willem J M Mulder; Roland Proksa; Zahi A Fayad
Related Documents :
8790028 - Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic compon...
18657388 - Multidetector-row computed tomography in evaluation of atherosclerotic carotid plaques ...
12117718 - Mri and characterization of atherosclerotic plaque: emerging applications and molecular...
2692398 - Computer imaging analysis of glomerular extracellular components in patients with iga n...
9717888 - Diagnostic value of spiral-ct angiography in comparison with digital subtraction angiog...
20510538 - Role of positron emission tomography in the treatment of occult disease in head-and-nec...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-07-28
Journal Detail:
Title:  Radiology     Volume:  256     ISSN:  1527-1315     ISO Abbreviation:  Radiology     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-19     Completed Date:  2010-09-30     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  0401260     Medline TA:  Radiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  774-82     Citation Subset:  AIM; IM    
Copyright Information:
(c) RSNA 2010.
Affiliation:
Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aortic Diseases / pathology,  radiography*
Atherosclerosis / pathology,  radiography*
Color
Contrast Media / diagnostic use
Gold / diagnostic use*
Iodine / diagnostic use
Mice
Mice, Knockout
Microscopy, Confocal
Microscopy, Electron
Nanoparticles / diagnostic use*
Phantoms, Imaging
Tomography, X-Ray Computed / methods*
Grant Support
ID/Acronym/Agency:
K99 EB012165-01/EB/NIBIB NIH HHS; R01 EB009638/EB/NIBIB NIH HHS; R01 EB009638-07/EB/NIBIB NIH HHS; R01 HL61814/HL/NHLBI NIH HHS; R01 HL71021/HL/NHLBI NIH HHS; R01 HL78667/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Contrast Media; 7440-57-5/Gold; 7553-56-2/Iodine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identification and characterization of deer astroviruses.
Next Document:  Plasma coenzyme Q10 levels and postmenopausal breast cancer risk: the multiethnic cohort study.